Skip to main content
. 2018 Jun 5;13(6):e0198478. doi: 10.1371/journal.pone.0198478

Fig 6. Anti-HIV-1 activity of compound 2 (black line) and tenofovir (T, grey line) in gel, formulation, in human TZM-bl cell line.

Fig 6

Each concentration of both compounds was evaluated in triplicate.